Protocol Number:  TA-303                           10/2009 - Present

Sponsor:  Vivus, Inc.

Title:  A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy

Purpose of Study

The purpose of this study is to evaluate the safety and efficacy of two doses of Avanafil (100 mg and 200 mg) in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

For further information click here

Protocol Number:  H6D-MC-LVFN                  08/2003 – 03/2004
Sponsor:  Lilly ICOS
Title:  An open-label study to evaluate the efficacy and safety of Tadalafil administered “on demand” to men of various populations with erectile dysfunction.

Clinical Research Coordinators:
Patricia Edwards, RN (336) 274-1114 ext. 5322
Karen Michael, RN (336) 274-1114 ext. 5328
E-mail address: research@allianceurology.com